2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 51, Issue 1, 2018, Pages 1-17

  Kung, Hsiang Chi ^a   Huang, Po Yen ^b   Chen, Wei Ting ^c   Ko, Bor Sheng ^a,d   Chen, Yee Chun ^a,d   Chang, Shan Chwen ^a,d   Chuang, Yin Ching ^e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Antifungal therapy; Aspergillosis; Candidiasis; Cryptococcosis; Definitive therapy; Mucormycosis

Indexed keywords

ANTIFUNGAL AGENT;

APOPHYSOMYCES; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; CUNNINGHAMELLA; DRUG USE; EUROTIALES; FILOBASIDIELLA; HUMAN; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; LICHTHEIMIA; MUCOR; MUCORMYCOSIS; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; RHIZOMUCOR; RHIZOPUS; SAKSENAEA; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; TAIWAN; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; DRUG EFFECT; DRUG INTERACTION; FOOD DRUG INTERACTION; MICROBIOLOGY; MYCOSIS; PATHOGENICITY; STANDARDS;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; GUIDELINES AS TOPIC; HUMANS; INVASIVE FUNGAL INFECTIONS; MUCORMYCOSIS; MYCOSES; TAIWAN;

EID: 85026780684     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2017.07.006     Document Type: Review

References (75)

1. Chen, C.Y., Kumar, R.N., Feng, Y.H., Ho, C.H., You, J.Y., Liao, C.C., et al. Treatment outcomes in patients receiving conventional amphotericin B therapy: a prospective multicentre study in Taiwan. J Antimicrob Chemother 57 (2006), 1181–1188.
2. Hung, C.C., Chen, Y.C., Chang, S.C., Luh, K.T., Hsieh, W.C., Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 95 (1996), 19–28.
3. Chen, P.Y., Chuang, Y.C., Wang, J.T., Sheng, W.H., Yu, C.J., Chu, C.C., et al. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect 47 (2014), 95–103.
4. Hii, I.M., Chang, H.L., Lin, L.C., Lee, Y.L., Liu, Y.M., Liu, C.E., et al. Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect 48 (2015), 306–315.
5. Tseng, H.K., Liu, C.P., Ho, M.W., Lu, P.L., Lo, H.J., Lin, Y.H., et al. Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997–2010. PLoS One, 8, 2013, e61921.
6. Hsiue, H.C., Wu, T.H., Chang, T.C., Hsiue, Y.C., Huang, Y.T., Lee, P.I., et al. Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000–2009. Eur J Clin Microbiol Infect Dis 31 (2012), 1319–1326.
7. Brown, G.D., Denning, D.W., Gow, N.A., Levitz, S.M., Netea, M.G., White, T.C., Hidden killers: human fungal infections. Sci Transl Med, 4, 2012, 165rv113.
8. Chen, Y.C., Lin, S.F., Liu, C.J., Jiang, D.D., Yang, P.C., Chang, S.C., Risk factors for ICU mortality in critically ill patients. J Formos Med Assoc 100 (2001), 656–661.
9. Kish, M.A., Infectious Diseases Society of A. Guide to development of practice guidelines. Clin Infect Dis 32 (2001), 851–854.
10. Infectious Diseases Society of T, Medical Foundation in Memory of Dr. Deh-Lin C, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases R, Education, Diseases CYLsRFfPI, Vaccine, Guidelines for the use of antifungal agents in patients with invasive fungal infections in Taiwan. J Microbiol Immunol Infect 39 (2006), 523–525.
11. Infectious Diseases Society of T, Hematology Society of T, Taiwan Society of P, Critical Care M, Medical Foundation in Memory of Dr Deh-Lin C, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases R, et al. Guidelines for the use of antifungal agents in patients with invasive fungal infections in Taiwan–revised 2009. J Microbiol Immunol Infect 43 (2010), 258–263.
12. De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46 (2008), 1813–1821.
13. Perfect, J.R., Dismukes, W.E., Dromer, F., Goldman, D.L., Graybill, J.R., Hamill, R.J., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 50 (2010), 291–322.
14. Pappas, P.G., Kauffman, C.A., Andes, D.R., Clancy, C.J., Marr, K.A., Ostrosky-Zeichner, L., et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62 (2016), e1–50.
15. Patterson, T.F., Thompson, G.R. 3rd, Denning, D.W., Fishman, J.A., Hadley, S., Herbrecht, R., et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63 (2016), e1–e60.
16. Mousset, S., Buchheidt, D., Heinz, W., Ruhnke, M., Cornely, O.A., Egerer, G., et al. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 93 (2014), 13–32.
17. Skiada, A., Lanternier, F., Groll, A.H., Pagano, L., Zimmerli, S., Herbrecht, R., et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 98 (2013), 492–504.
18. Maertens, J., Marchetti, O., Herbrecht, R., Cornely, O.A., Fluckiger, U., Frere, P., et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3–2009 update. Bone Marrow Transpl 46 (2011), 709–718.
19. Cornely, O.A., Arikan-Akdagli, S., Dannaoui, E., Groll, A.H., Lagrou, K., Chakrabarti, A., et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20:Suppl 3 (2014), 5–26.
20. Ullmann, A.J., Cornely, O.A., Donnelly, J.P., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect 18:Suppl 7 (2012), 1–8.
21. Guyatt, G.H., Oxman, A.D., Schunemann, H.J., Tugwell, P., Knottnerus, A., GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 64 (2011), 380–382.
22. Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
23. US GRADE Network, Approach and implications to rating the quality of evidence and strength of recommendations using the GRADE methodology. Available at: http://www.gradeworkinggroup.org/ [Accessed 14 October 2016].
24. Pfaller, M.A., Diekema, D.J., Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 (2007), 133–163.
25. Liu, C.Y., Liao, C.H., Chen, Y.C., Chang, S.C., Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006. J Microbiol Immunol Infect 43 (2010), 416–429.
26. Chen, L.Y., Liao, S.Y., Kuo, S.C., Chen, S.J., Chen, Y.Y., Wang, F.D., et al. Changes in the incidence of candidaemia during 2000–2008 in a tertiary medical centre in northern Taiwan. J Hosp Infect 78 (2011), 50–53.
27. Chuang, Y.C., Chen, Y.C., Chang, S.C., Sun, C.C., Chang, Y.Y., Chen, M.L., et al. Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981–2007. J Hosp Infect 76 (2010), 143–149.
28. Chen, Y.C., Chang, S.C., Sun, C.C., Yang, L.S., Hsieh, W.C., Luh, K.T., Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 18 (1997), 369–375.
29. TNIS Annual Report of Nosocomial Surveillance System. 2013, CDC, Taiwan Available at: http://www.cdc.gov.tw/english/downloadfile.aspx?fid=BB5FF536F770C40A, [Accessed 1 December 2016].
30. Sheng, W.H., Wang, J.T., Lu, D.C., Chie, W.C., Chen, Y.C., Chang, S.C., Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres. J Hosp Infect 59 (2005), 205–214.
31. Davis, S.L., Vazquez, J.A., McKinnon, P.S., Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother 41 (2007), 568–573.
32. Ruan, S.Y., Hsueh, P.R., Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc 108 (2009), 443–451.
33. Tan, B.H., Chakrabarti, A., Li, R.Y., Patel, A.K., Watcharananan, S.P., Liu, Z., et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 21 (2015), 946–953.
34. Eggimann, P., Garbino, J., Pittet, D., Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3 (2003), 685–702.
35. Lai, H.P., Chen, Y.C., Chang, L.Y., Lu, C.Y., Lee, C.Y., Lin, K.H., et al. Invasive fungal infection in children with persistent febrile neutropenia. J Formos Med Assoc 104 (2005), 174–179.
36. Chen, Y.C., Chang, S.C., Luh, K.T., Hsieh, W.C., Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrob Chemother 52 (2003), 71–77.
37. Huang, Y.T., Liu, C.Y., Liao, C.H., Chung, K.P., Sheng, W.H., Hsueh, P.R., Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009–2010. Antimicrob Agents Chemother 58 (2014), 3814–3819.
38. Ruan, S.Y., Chu, C.C., Hsueh, P.R., In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrob Agents Chemother 52 (2008), 2919–2922.
39. Chen, T.C., Chen, Y.H., Chen, Y.C., Lu, P.L., Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents. Kaohsiung J Med Sci 28 (2012), 306–315.
40. Chen, Y.C., Chang, S.C., Tai, H.M., Hsueh, P.R., Luh, K.T., Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 100 (2001), 791–797.
41. Nucci, M., Anaissie, E., How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach. Blood 124 (2014), 3858–3869.
42. Voss, A., Hollis, R.J., Pfaller, M.A., Wenzel, R.P., Doebbeling, B.N., Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 32 (1994), 975–980.
43. Yang, S.P., Chen, Y.Y., Hsu, H.S., Wang, F.D., Chen, L.Y., Fung, C.P., A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis, 13, 2013, 10.
44. Chen, C.Y., Chen, Y.C., Tang, J.L., Yao, M., Huang, S.Y., Tsai, W., et al. Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann Hematol 82 (2003), 93–97.
45. Huang, Y.C., Su, L.H., Wu, T.L., Lin, T.Y., Genotyping analysis of colonizing candidal isolates from very-low-birthweight infants in a neonatal intensive care unit. J Hosp Infect 58 (2004), 200–203.
46. Binelli, C.A., Moretti, M.L., Assis, R.S., Sauaia, N., Menezes, P.R., Ribeiro, E., et al. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect 12 (2006), 538–543.
47. Dalle, F., Lafon, I., L'Ollivier, C., Ferrant, E., Sicard, P., Labruere, C., et al. A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia. Haematologica 93 (2008), 581–587.
48. Huang, P.Y., Hung, M.H., Shie, S.S., Su, L.H., Chen, K.Y., Ye, J.J., et al. Molecular concordance of concurrent Candida albicans candidemia and candiduria. Diagn Microbiol Infect Dis 76 (2013), 382–384.
49. Fisher, J.F., Sobel, J.D., Kauffman, C.A., Newman, C.A., Candida urinary tract infections–treatment. Clin Infect Dis 52:Suppl 6 (2011), S457–S466.
50. Georgiadou, S.P., Tarrand, J., Sipsas, N.V., Kontoyiannis, D.P., Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?. Mycoses 56 (2013), 311–314.
51. Pittet, D., Monod, M., Suter, P.M., Frenk, E., Auckenthaler, R., Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220 (1994), 751–758.
52. Barton, M., O'Brien, K., Robinson, J.L., Davies, D.H., Simpson, K., Asztalos, E., et al. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls. BMC Infect Dis, 14, 2014, 327.
53. Zaoutis, T.E., Heydon, K., Localio, R., Walsh, T.J., Feudtner, C., Outcomes attributable to neonatal candidiasis. Clin Infect Dis 44 (2007), 1187–1193.
54. Jean, S.S., Fang, C.T., Shau, W.Y., Chen, Y.C., Chang, S.C., Hsueh, P.R., et al. Cryptococcaemia: clinical features and prognostic factors. QJM 95 (2002), 511–518.
55. Day, J.N., Chau, T.T., Wolbers, M., Mai, P.P., Dung, N.T., Mai, N.H., et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med 368 (2013), 1291–1302.
56. Sun, H.Y., Wagener, M.M., Singh, N., Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. Clin Infect Dis 48 (2009), 1566–1576.
57. Shih, C.C., Chen, Y.C., Chang, S.C., Luh, K.T., Hsieh, W.C., Cryptococcal meningitis in non-HIV-infected patients. QJM 93 (2000), 245–251.
58. Rolfes, M.A., Hullsiek, K.H., Rhein, J., Nabeta, H.W., Taseera, K., Schutz, C., et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. Clin Infect Dis 59 (2014), 1607–1614.
59. Boulware, D.R., Meya, D.B., Muzoora, C., Rolfes, M.A., Huppler Hullsiek, K., Musubire, A., et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med 370 (2014), 2487–2498.
60. Blot, S.I., Taccone, F.S., Van den Abeele, A.M., Bulpa, P., Meersseman, W., Brusselaers, N., et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 186 (2012), 56–64.
61. Taccone, F.S., Van den Abeele, A.M., Bulpa, P., Misset, B., Meersseman, W., Cardoso, T., et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care, 19, 2015, 7.
62. Tang, J.L., Kung, H.C., Lei, W.C., Yao, M., Wu, U.I., Hsu, S.C., et al. High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: a prospective observational study in Taiwan. PLoS One, 10, 2015, e0128410.
63. Chen, K.Y., Ko, S.C., Hsueh, P.R., Luh, K.T., Yang, P.C., Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest 120 (2001), 177–184.
64. Chen, C.Y., Sheng, W.H., Cheng, A., Chen, Y.C., Tsay, W., Tang, J.L., et al. Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan. BMC Infect Dis, 11(250), 2011 Sep 22, 2009.
65. Wu, C.J., Wang, H.C., Lee, J.C., Lo, H.J., Dai, C.T., Chou, P.H., et al. Azole-resistant Aspergillus fumigatus isolates carrying TR(3)(4)/L98H mutations in Taiwan. Mycoses 58 (2015), 544–549.
66. Pfaller, M.A., Pappas, P.G., Wingard, J.R., Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 43 (2006), S3–S14.
67. Leeflang, M.M., Debets-Ossenkopp, Y.J., Wang, J., Visser, C.E., Scholten, R.J., Hooft, L., et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev, 2015, CD007394.
68. Marr, K.A., Schlamm, H.T., Herbrecht, R., Rottinghaus, S.T., Bow, E.J., Cornely, O.A., et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med 162 (2015), 81–89.
69. Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., Marchetti, O., Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 46 (2008), 201–211.
70. Ramage, G., Jose, A., Sherry, L., Lappin, D.F., Jones, B., Williams, C., Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms. Antimicrob Agents Chemother 57 (2013), 2369–2371.
71. Yokoe, D., Casper, C., Dubberke, E., Lee, G., Munoz, P., Palmore, T., et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transpl 44 (2009), 495–507.
72. Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T.J., Kontoyiannis, D.P., Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:Suppl 1 (2012), S23–S34.
73. Wang, J.L., Hsiao, C.H., Chang, S.C., Hsueh, P.R., Chen, Y.C., Diagnostic challenge of zygomycosis in compromised hosts. Med Mycol 44 (2006), 19–24.
74. Vitale, R.G., de Hoog, G.S., Schwarz, P., Dannaoui, E., Deng, S., Machouart, M., et al. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales. J Clin Microbiol 50 (2012), 66–75.
75. Ibrahim, A.S., Gebremariam, T., Husseiny, M.I., Stevens, D.A., Fu, Y., Edwards, J.E. Jr., et al. Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Antimicrob Agents Chemother 52 (2008), 1573–1576.